Mark O’Mahony's most recent trade in Leap Therapeutics Inc was a trade of 22,500 Common Stock done . Disclosure was reported to the exchange on March 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 22,500 | 27,500 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 22,500 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | O’Mahony Mark | Chief Manufacturing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 5,000 | 5,000 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | O’Mahony Mark | Chief Manufacturing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 225,000 | 225,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |